STUDY OBJECTIVES: (1) To determine the efficacy of automatically adjusted positive airway pressure (APAP) with a comfort feature (A-Flex) at reducing apneas and hypopneas in participants with moderate to severe OSA. (2) To determine the relative difference between A-Flex, continuous positive airway pressure (CPAP), and APAP-derived optimal pressure for CPAP (CPAP(APAP)) on adherence to treatment. (3) To determine the relative difference between APAP with A-Flex, CPAP, and CPAP(APAP) on long-term change in functional outcomes. DESIGN: Randomized, double-blinded, 3-arm, multicenter trial. SETTING:University and Veterans Affairs medical centers. PATIENTS OR PARTICIPANTS: 168 participants were randomized, and 140 completed the 180-day study. INTERVENTIONS: (1) A-Flex; (2) CPAP; (3) APAP for 14 days and then switched to CPAP at a fixed pressure. MEASUREMENTS AND RESULTS:Apnea-hypopnea indices, average and minimum oxygen saturation, time spent < 90% were significantly poorer for A-Flex vs. CPAP at the initiation of study treatment; with the exception of minimum oxygen saturation, these differences were absent at 180 days. A-Flex had lower average leak values at both 3 and 6 months. There were no significant differences between groups in major efficacy, adherence, and outcome (subjective sleepiness, objective vigilance, blood pressure, quality of life) measures. No differences between groups in attitudes toward use were observed at 3 or 6 months; participant ratings for CPAP were significantly higher than A-Flex on treatment satisfaction and benefit, but not different for sleep quality and mask comfort. CONCLUSIONS: We found that A-Flex shows equivalency, but non-superiority (except for average leak values), in efficacy, adherence, and functional outcomes compared to CPAP after either 3 or 6 months. CLINICAL TRIAL REGISTRY: Positive Pressure Treatment of Obstructive Sleep Apnea, http://www.clinicaltrials.gov, NCT00636181.
RCT Entities:
STUDY OBJECTIVES: (1) To determine the efficacy of automatically adjusted positive airway pressure (APAP) with a comfort feature (A-Flex) at reducing apneas and hypopneas in participants with moderate to severe OSA. (2) To determine the relative difference between A-Flex, continuous positive airway pressure (CPAP), and APAP-derived optimal pressure for CPAP (CPAP(APAP)) on adherence to treatment. (3) To determine the relative difference between APAP with A-Flex, CPAP, and CPAP(APAP) on long-term change in functional outcomes. DESIGN: Randomized, double-blinded, 3-arm, multicenter trial. SETTING: University and Veterans Affairs medical centers. PATIENTS OR PARTICIPANTS: 168 participants were randomized, and 140 completed the 180-day study. INTERVENTIONS: (1) A-Flex; (2) CPAP; (3) APAP for 14 days and then switched to CPAP at a fixed pressure. MEASUREMENTS AND RESULTS:Apnea-hypopnea indices, average and minimum oxygen saturation, time spent < 90% were significantly poorer for A-Flex vs. CPAP at the initiation of study treatment; with the exception of minimum oxygen saturation, these differences were absent at 180 days. A-Flex had lower average leak values at both 3 and 6 months. There were no significant differences between groups in major efficacy, adherence, and outcome (subjective sleepiness, objective vigilance, blood pressure, quality of life) measures. No differences between groups in attitudes toward use were observed at 3 or 6 months; participant ratings for CPAP were significantly higher than A-Flex on treatment satisfaction and benefit, but not different for sleep quality and mask comfort. CONCLUSIONS: We found that A-Flex shows equivalency, but non-superiority (except for average leak values), in efficacy, adherence, and functional outcomes compared to CPAP after either 3 or 6 months. CLINICAL TRIAL REGISTRY: Positive Pressure Treatment of Obstructive Sleep Apnea, http://www.clinicaltrials.gov, NCT00636181.
Authors: Nigel McArdle; Bhajan Singh; Michelle Murphy; Kevin R Gain; Christine Maguire; Sarah Mutch; David R Hillman Journal: Thorax Date: 2010-07 Impact factor: 9.139
Authors: Ingo Fietze; Martin Glos; Isabel Moebus; Christian Witt; Thomas Penzel; Gert Baumann Journal: Respiration Date: 2007-02-23 Impact factor: 3.580
Authors: Oliver Senn; Thomas Brack; Felix Matthews; Erich W Russi; Konrad E Bloch Journal: Am J Respir Crit Care Med Date: 2003-10-02 Impact factor: 21.405
Authors: Jessica Evans; Robert Skomro; Helen Driver; Brian Graham; Irvin Mayers; Louise McRae; Joseph Reisman; Corneliu Rusu; Teresa To; John Fleetham Journal: Can Respir J Date: 2013-11-28 Impact factor: 2.409
Authors: Susheel P Patil; Indu A Ayappa; Sean M Caples; R Joh Kimoff; Sanjay R Patel; Christopher G Harrod Journal: J Clin Sleep Med Date: 2019-02-15 Impact factor: 4.062
Authors: Richard B Berry; Clete A Kushida; Meir H Kryger; Haideliza Soto-Calderon; Bethany Staley; Samuel T Kuna Journal: Sleep Date: 2012-03-01 Impact factor: 5.849
Authors: Shelley R Knowles; Daniel T O'Brien; Shiling Zhang; Anupama Devara; James A Rowley Journal: J Clin Sleep Med Date: 2014-04-15 Impact factor: 4.062
Authors: Cynthia Y Callahan; Robert G Norman; Zachary Taxin; Anne M Mooney; David M Rapoport; Indu Ayappa Journal: Sleep Date: 2013-04-01 Impact factor: 5.849
Authors: Manya Somiah; Zachary Taxin; Joseph Keating; Anne M Mooney; Robert G Norman; David M Rapoport; Indu Ayappa Journal: J Clin Sleep Med Date: 2012-10-15 Impact factor: 4.062
Authors: Bharati Prasad; David W Carley; Jerry A Krishnan; Terri E Weaver; Frances M Weaver Journal: J Clin Sleep Med Date: 2012-10-15 Impact factor: 4.062
Authors: Ian M Colrain; Jed Black; Lawrence C Siegel; Richard K Bogan; Philip M Becker; Mehran Farid-Moayer; Rochelle Goldberg; D Alan Lankford; Andrew N Goldberg; Atul Malhotra Journal: Sleep Med Date: 2013-07-17 Impact factor: 3.492